Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Kava ban broadens

This article was originally published in The Tan Sheet

Executive Summary

French health agency L'Afssaps plans to suspend sale of kava-containing products, excluding homeopathic items. In Jan. 9 statement, L'Afssaps cites 30 AEs in Germany and Switzerland, including reports that one person died and four required liver transplants, but notes it has not received AEs in France. DGCCRF, the French agency governing fraud, has spoken with two professional organizations about "suspending the utilization and deliverance" of such products, according to L'Afssaps. Last month, the UK supplement industry agreed to Medicines Control Agency's request that kava supplements be pulled from store shelves (1"The Tan Sheet" Dec. 24, 2001, p. 14)...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS093497

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel